Get the Stockscreener App
37.85
1.26%
0.47
After Hours:
38.00
0.15
+0.40%
Astrana Health Inc stock is traded at $37.85, with a volume of 375.88K.
It is up +1.26% in the last 24 hours and up +12.31% over the past month.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
See More
Previous Close:
$37.38
Open:
$37.54
24h Volume:
375.88K
Relative Volume:
0.77
Market Cap:
$1.88B
Revenue:
$3.18B
Net Income/Loss:
$24.08M
P/E Ratio:
82.99
EPS:
0.4561
Net Cash Flow:
$104.49M
1W Performance:
-1.07%
1M Performance:
+12.31%
6M Performance:
+68.22%
1Y Performance:
+54.68%
1-Day Range:
$37.27
$37.93
1-Week Range:
$36.95
$39.87
52-Week Range:
$18.08
$39.93
Astrana Health Inc Stock (ASTH) Company Profile
Name
Astrana Health Inc
Sector
Industry
Phone
(626) 282-0288
Address
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASTH
Astrana Health Inc
|
37.85 | 1.85B | 3.18B | 24.08M | 104.49M | 0.4561 |
HCA
Hca Healthcare Inc
|
394.07 | 87.09B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
173.78 | 15.33B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
198.52 | 12.75B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
21.64 | 12.09B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
104.96 | 10.36B | 6.07B | 793.80M | 464.40M | 5.9914 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Initiated | Needham | Buy |
| Apr-01-25 | Initiated | Barclays | Equal Weight |
| Oct-14-24 | Initiated | TD Cowen | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-11-24 | Upgrade | Truist | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Feb-26-24 | Initiated | Jefferies | Buy |
| Feb-22-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-24 | Initiated | Stifel | Buy |
| Dec-22-23 | Initiated | Truist | Hold |
| Oct-17-23 | Initiated | BTIG Research | Buy |
| Apr-12-23 | Initiated | BofA Securities | Neutral |
| Dec-19-22 | Initiated | Lake Street | Buy |
| Sep-21-22 | Initiated | William Blair | Outperform |
| Jan-11-22 | Resumed | Colliers Securities | Buy |
| Aug-12-21 | Initiated | Barclays | Equal Weight |
View All
Astrana Health Inc Stock (ASTH) Latest News
Astrana Health closes deal with Prospect Health at a lower price - MSN
A Look at Astrana Health Inc (ASTH) After 3.5% Decline -- GF Val - GuruFocus
Cash-Rich Stocks: Appian and Array Face Challenges, Astrana Health ShinesNews and Statistics - IndexBox
Is Astrana’s Q1 Results and AI Platform Push Altering The Investment Case For Astrana Health (ASTH)? - Yahoo Finance
Astrana Health (ASTH) price target increased by 18.07% to 44.43 - MSN
52-Week High Stocks: Sell EchoStar, Watch Vita Coco and Astrana HealthNews and Statistics - IndexBox
Astrana Health (ASTH) COO and CFO surrenders 8,155 shares for tax withholding - Stock Titan
Astrana Health partners with California physician group By Investing.com - Investing.com Nigeria
Astrana Health says Prospect deal is ahead of schedule as Q1 trends beat expectations - MSN
Astrana Health Q1 2026 Results: Revenue Beat and AI-Driven Growth - IndexBox
5 Revealing Analyst Questions From Astrana Health’s Q1 Earnings Call - Yahoo Finance
Will Strong Q1 Results and New Leadership Shift Astrana Health's (ASTH) Value-Based Care Narrative - simplywall.st
Baird Lifts PT on Astrana Health (ASTH) Following Q1 Results - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Astrana Health (ASTH), Bristol-Myers Squibb (BMY) and Progyny (PGNY) - The Globe and Mail
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $47 - Moomoo
Truist raises Astrana Health stock price target to $47 on outlook - Investing.com UK
Truist raises Astrana Health stock price target to $47 on outlook By Investing.com - Investing.com South Africa
BofA Securities Maintains Astrana Health(ASTH.US) With Buy Rating - Moomoo
Astrana Health Updates Investor Presentation via Regulation FD Disclosure - The Globe and Mail
Astrana Health Inc.Common Stock (NQ: ASTH - FinancialContent
Astrana Health names George Christides interim medical director By Investing.com - Investing.com Australia
Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations - Inkl
Astrana Health names George Christides interim medical director - Investing.com UK
ASTH Q1 Deep Dive: AI-Enabled Platform, Full-Risk Expansion, and Operating Leverage Shape Results - Yahoo Finance
Astrana Health announces appointment of interim national medical director - marketscreener.com
Astrana Health, Inc. Announces Appointment of Interim National Medical Director - PR Newswire
Astrana outlines $3.8B-$4.1B 2026 revenue outlook as net leverage targets at or below 2x - MSN
Astrana Health Announces Upcoming Chief Medical Officer Resignation - TipRanks
Astrana Health chief medical officer Dinesh Kumar to resign effective June 1 - Investing.com
Astrana Health chief medical officer Dinesh Kumar to resign effective June 1 By Investing.com - Investing.com South Africa
Astrana Health (NASDAQ: ASTH) CMO Dinesh Kumar plans June 1, 2026 exit - Stock Titan
Astrana Health (NASDAQ: ASTH) posts updated May 2026 investor presentation - Stock Titan
Astrana Health partners with California physician group - Investing.com UK
Astrana Health : Physician Association of California and Astrana Health Launch Collaboration to Strengthen Independent Primary Care - marketscreener.com
Earnings call transcript: Astrana Health Q1 2026 Surpasses Expectations with Strong EPS and Revenue Growth - Investing.com Nigeria
Astrana Health partners with PAC to boost independent physicians via AI-driven Medicare ACO platform. - Pluang
Astrana Health Inc Stock (ASTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.74%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):